Ortho Clinical Diagnostics’ COVID-19 Antibody Assays Cleared in Europe

Ortho Clinical Diagnostics has received CE mark certification for its Vitros Anti-SARS-CoV-2 Total 2 antibody assay and Vitros Anti-SARS-CoV-2 IgG 2 antibody assay, a pair of qualitative and semi-quantitative tests for detecting COVID-19 antibodies.

The two tests help to shed light on a patient’s adaptive immune response mounted naturally after infection or through vaccination. Additionally, they can be used to assess levels of neutralizing antibodies and identify plasma samples adequate for use in convalescent plasma therapy.

The assays are run on the company’s automated analyzers, including its flagship Vitros XT 7600 Integrated System, its Vitros 3600 Immunodiagnostic System, its Vitros 5600 Integrated System and its Vitros ECi/ECiQ Immunodiagnostic System.